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OBJECTIVES The purpose of this study was to answer the question of whether stimulation after
administration of catecholamines is mandatory for identifying unsuccessful ablations of
atrioventricular node re-entrant tachycardia (AVNRT).
BACKGROUND The success of radiofrequency (RF) catheter ablation in AVNRT is confirmed in many
centers by noninducibility of tachycardias during stimulation after the administration of
catecholamines.
METHODS A total of 131 patients (81 women and 50 men; mean age 53.6 13.7 years [range 20 to 77])
were studied. Electrical stimulation was performed without and with the beta-adrenergic
amine Orciprenaline (metaproterenol) before and after RF catheter ablation.
RESULTS In 100 patients (76.3%; confidence interval [CI] 68.1% to 83.3%) an AVNRT was inducible
without administration of Orciprenaline. Thirty minutes after the initially successful ablation
in 95 patients, tachycardia was inducible in none of these patients, not even after
Orciprenaline administration. In the 31 patients (23.7%; CI 16.7% to 31.9%) in whom there
was no tachycardia inducible before ablation, Orciprenaline was given, and the stimulation
protocol was repeated. In only five patients (3.8%; CI 1.3% to 8.7%) was there still no
tachycardia inducible. After an initially successful ablation in the 26 patients who had
inducible tachycardias with Orciprenaline before ablation, no tachycardia could be re-
induced. After Orciprenaline, the tachycardia was inducible again in only one patient.
CONCLUSIONS Only patients who require catecholamines for tachycardia induction before ablation need
catecholamines for control of the success of the ablation of AVNRT. (J Am Coll Cardiol
2002;39:689–94) © 2002 by the American College of Cardiology
Radiofrequency (RF) catheter ablation of atrioventricular
node re-entrant tachycardia (AVNRT) by modulation or
ablation of slowly conducting atrioventricular (AV) nodal
pathways is a routine procedure in cardiology centers (1).
For many authors, successful ablation of AVNRT is proven
only by noninducibility of the tachycardia after administra-
tion of catecholamines (2–7). Isoproterenol, the most potent
sympathomimetic amine, which acts almost exclusively on
beta-receptors, was widely used for this purpose in the U.S.
up to now (8). Orciprenaline (metaproterenol; Alupent,
Boehringer Ingelheim, Ingelheim, Germany) is widely used
for this administration in Germany. It is a beta-receptor
agonist that is similar to isoproterenol (8). The purpose of
this study was to answer the question of whether an
additional electrical stimulation after administration of a
beta-adrenergic agonist, after a primarily successful ablation
of AVNRT, is required.
METHODS
Study group. In the present study, 131 consecutive patients
(50 men and 81 women) with AVNRT were included. All
patients complained of a paroxysmal, rapid heart rate. In
most patients, a regular tachycardia was documented by
electrocardiography (12-lead, Holter monitoring). The
mean age of the patients was 53.5  13.7 years (range 20 to
77). In 26 patients, a structural cardiac disease was present.
Twenty patients had coronary artery disease; three patients
had dilated cardiomyopathy; one patient had coronary artery
disease and a moderate aortic stenosis; one patient had a cor
pulmonale due to structural lung disease; and one patient
had an atrial septal defect that had previously been closed.
One hundred five patients had no signs of structural heart
disease, as detected by electrocardiography, transthoracic
echocardiography, treadmill testing, and coronary angiog-
raphy in men older than 39 years and in women older than
44 years.
Electrophysiologic diagnostic procedure. On the day be-
fore the procedure, all patients gave written, informed
consent to undergo the intended electrophysiologic study
and ablation. For sedation and analgesia, 5 mg of diazepam
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and 5 mg of morphine sulfate were given intravenously. All
anti-arrhythmic drugs were stopped earlier than five half-
lives before the procedure. The ablation was performed after
a bolus injection of 5,000 IU of heparin. Two 4-pole, 6F
electrode catheters (Bard, Billerica, Massachusetts), with a
5-mm interelectrode distance, were introduced over the
femoral veins and placed in the right atrial appendage and at
the His bundle. The tip of a bipole, 5F electrode catheter
(Cordis, Watertown, Massachusetts) was placed in the apex
of the right ventricle through a femoral vein.
Another electrode catheter with 10 poles and an inter-
electrode distance of 2 mm (Bard) was inserted into the
proximal coronary sinus through the left antecubital vein or
the right internal jugular vein. All 12-surface electrocardio-
graphic (ECG) leads were stored with the intracardiac
electrograms, using a multi-channel recording system (Bard,
LabSystems version 2.57/2.58), and stored on an optical
disk.
Programmed electrical stimulation was performed with
the UHS-20 stimulation device (Biotronik, Lo¨rrach, Ger-
many). The impulse width was 2.0 ms. The atrial and
ventricular stimulation thresholds were determined at the
beginning of the procedure to be 0.5 to 1.5 V. The
stimulation amplitude was adjusted to twice the diastolic
threshold. Programmed stimulation was performed in all
patients, according to the following protocol:
• Determination of the sinus node recovery time at rates of
120 to 200/min.
• Determination of the effective refractory period of the
right atrium and the anterograde conduction of the AV
node by a single atrial extrastimulus, with 10-ms decre-
mental shortening of the coupling interval after seven
basic cycles during sinus rhythm and during stimulation
with a heart rate of 100, 120, 150 and 180 beats/min, if
needed.
• Incremental atrial stimulation for the determination of
the maximal rate with 1:1 AV conduction.
• Incremental ventricular stimulation to detect the maximal
rate with retrograde 1:1 AV conduction.
• Determination of the effective refractory period of the
right ventricle and the conduction in ventriculo-atrial
direction with a single extrastimulus during a basic cycle
length of 500 ms from the apex of the right ventricle.
If there was no tachycardia inducible by a single extra-
stimulus, atrial double stimuli were applied during a basic
cycle length of 330 to 600 ms. If no tachycardia was
inducible by these stimulation maneuvers, the entire stim-
ulation protocol was repeated after intravenous administra-
tion of Orciprenaline. The dose was adjusted to a heart rate
of 50% above the initial sinus rate of the patient. For this
purpose, 0.25 to 1.0 mg of Orciprenaline was needed.
After the induction of supraventricular tachycardias, the
diagnosis of tachycardia was based on generally accepted
criteria (4,9,10). The induced forms of AVNRT were
defined as (1): typical AVNRT (the slow-fast form) and
atypical AVNRT (the fast-slow form). The slow-slow form
of AVNRT pertains to conduction of the impulse exclu-
sively through two slowly conducting AV nodal pathways
during tachycardia.
Dual AV node conduction properties were accepted as
present if the A2-H2 interval (AH) increased by 50 ms
during atrial extrastimulation, with 10-ms shortening of the
coupling interval of the extrastimulus.
Ablation. We applied RF energy at the site of the slowly
conducting AV nodal pathway. A 4-mm-long tip of a
4-pole, deflectable, 7F ablation catheter (Cordis-Webster,
Watertown, Massachusetts) was placed through a long,
bent, 8F sheath (DAIG Corp., Minnetonka, Minnesota) at
the base of the triangle of Koch, according to anatomic and
electrophysiologic criteria, so that the relation of the atrial to
ventricular signal was 0.1 to 0.5, and a signal typical of a
slowly conducting pathway was detected (i.e., a late atrial
signal with high frequencies) (4,11).
For ablation, the RF generator EP-Shuttle (Stockert,
Cordis-Webster) was used. The energy was applied in a
temperature-guided mode, with a preselected temperature
of 70°C and a maximal energy of 30 W and a maximal
duration of 60 s.
The occurrence of junctional rhythms was assumed to
indicate a successful energy application (2,12). Energy
application was interrupted immediately if AV dissociation
occurred during accelerated junctional rhythm (13), if the
PR interval was prolonged, if an AV or ventriculo-atrial
block occurred or if there was a sudden rise in impedance
(14). After RF energy applications with accelerated AV
junctional rhythms, additional energy pulses (“safety puls-
es”) were applied, with a duration of 60 s. The end point of
ablation was noninducibility of AVNRT.
Control stimulation. Stimulation was applied in a mode
that was detected to induce the tachycardia before the first
energy application. The detection of an AH jump or the
occurrence of a single AV node echo beat was not consid-
ered as failure of ablation (15,16). However, if two consec-
utive AV node echo beats were recorded during stimulation,
additional energy applications were performed.
If no tachycardia was induced, the whole stimulation
protocol was repeated after a waiting period of 30 min.
In all patients in whom no AVNRT was inducible after
ablation, Orciprenaline was administered in a dose given for
tachycardia induction before ablation. During the Or-
ciprenaline effect, the whole stimulation protocol was re-
peated again. An AV nodal pathway was considered to be
Abbreviations and Acronyms
AH  A2-H2 interval
AV  atrioventricular
AVNRT  atrioventricular node re-entrant tachycardia
CI  confidence interval
ECG  electrocardiogram or electrocardiographic
RF  radiofrequency
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modulated if tachycardia was not inducible after the energy
application, and conduction over this AV nodal pathway
was detected by an AH jump or the occurrence of AV node
echo beats. An AV nodal pathway was considered to be
ablated if there was no conduction through this pathway
(i.e., if no AH jump or AV node echo beat was detectable
and the refractory period of the AV node was increased).
Procedure duration and radiation exposure. The whole
procedure of the electrophysiologic stimulation and abla-
tion, from the puncture of the veins until the removal of the
sheaths, including the waiting period, had a mean duration
of 218 60 min (confidence interval [CI] 206 to 230, range
90 to 380). The mean radiation duration was 28.1 
14.1 min (CI 23.4 to 32.8, range 5.0 to 58.0); and the mean
radiation exposure was 70  55 Gy cm2 (CI 57.5 to 82.0,
range 10 to 299). A mean number of 7.9  7.1 (median 6
[CI 6 to 7, range 1 to 44]) RF energy applications were
necessary. Because there were very short energy pulses, the
duration of all energy application was calculated (mean
268  209 s [CI 229 to 306, range 11 to 1,251], or 4.5 
3.5 min [CI 3.8 to 5.1, range 0.2 to 20.9]).
Monitoring after ablation. In all patients, the ECG was
monitored by telemetry up to the next morning. In all
patients, a 12-lead ECG was obtained, and an echocardio-
gram was obtained on the same or following day.
Statistics. For descriptive statistics, the mean or median
values, with 95% CIs, were calculated, as appropriate (17).
Data collection and calculations were performed on a
Windows PC with statistical software (MedCalc, version
6.00.012, Belgium; and Confidence Interval Analysis, ver-
sion 1.2, by Martin Gardner, London).
RESULTS
Inducible tachycardias. In 126 (96.2%) of 131 patients
(CI 91.3% to 98.8%), AVNRT was inducible, mostly the
typical form (114 [90.5%] of 126 patients of the patients
with inducible tachycardias [CI 84.0% to 95.0%]) (Table 1).
In five patients (3.8%; CI 1.3% to 8.7%), no tachycardia
could be induced during the electrophysiologic evaluation,
despite Orciprenaline administration.
Modulation or ablation of an AV nodal pathway by RF
energy application. In 126 (96.2%) of 131 patients (CI
91.3% to 98.8%), AVNRT was inducible. In the five
patients in whom no tachycardia was inducible, all of whom
had documented regular supraventricular tachycardia on the
ECG and an AH jump, RF energy was applied at the
typical site at the basis of Koch’s triangle, until junctional
rhythms were recorded. These patients were considered as
successfully ablated (18).
In 129 (98.5%) of all 131 patients (CI 94.6% to 99.8%),
the ablation procedure was successful. In two patients
(1.5%; CI 0.2% to 5.4%), successful ablation could not be
achieved. In one of these patients, the procedure was
stopped after the 40th RF energy pulse, and in another
patient with three AV nodal pathways, the procedure was
terminated after unintentional ablation of the fast-
conducting AV nodal pathway after the 8th energy pulse, to
avoid total AV block.
In three patients (2.3%; CI 0.5% to 6.6%), a complete AV
block occurred during the ablation procedure, which re-
quired pacemaker implantation.
In 31 patients (23.7%; CI 16.7% to 31.9%), no conduc-
tion through a slowly conducting AV nodal pathway was
detectable. Thus, the slowly conducting pathways were
considered ablated. In 90 patients (68.7%; CI 60.0% to
76.5%), one of the slowly conducting pathways was modu-
lated by the energy applications; conduction over these
pathways was recorded. However, tachycardias were not
inducible, not even after administration of Orciprenaline.
Inducibility of tachycardias before and after ablation.
INDUCIBILITY OF TACHYCARDIAS BEFORE ABLATION. As
outlined in the Methods section, electrical stimulation was
performed first without an additional adrenergic drug effect.
In 100 (76.3%) of all 131 patients (CI 68.1% to 83.3%),
tachycardias were inducible, whereas in 31 patients (23.7%;
CI 16.7% to 31.9%), no tachycardia was inducible without
additional measures (Fig. 1). In 26 (83.9%) of these 31
patients with primarily no inducible tachycardia (CI 66.3%
to 94.5%), AVNRT could be initiated by stimulation after
administration of Orciprenaline, and in the remaining 5
patients (16.1%; CI 5.5% to 33.7%), tachycardia induction
was not possible during the effect of Orciprenaline. In these
five patients, energy was applied at the presumed site of the
slowly conducting pathway (see previous paragraph). In this
subgroup, ablation was considered successful if, during
energy application, accelerated junctional rhythms were
recorded (18); this was the case in all five patients.
INDUCIBILITY OF TACHYCARDIAS AFTER ABLATION. There
were 121 patients with inducible tachycardias before abla-
tion who were considered successfully ablated after the last
energy pulse. Thirty minutes after ablation in these patients,
control stimulation was performed without the effect of
Orciprenaline. In none of these patients could AVNRT be
induced.
In all 95 patients with inducible tachycardias without
Orciprenaline administration before ablation, in whom
ablation was initially successful and there was no AV block,
electrophysiologic stimulation was repeated after adminis-
tration of Orciprenaline. Tachycardia was not inducible in
any of these patients. In the 26 (19.8%) of 131 patients (CI
Table 1. Forms of Induced AVNRT
n
Inducible AVNRTs 126
Only typical AVNRT 114
Only atypical AVNRT 5
Only slow-slow form of AVNRT 1
Typical AVNRT  atypical AVNRT 2
Typical AVNRT  slow-slow form of AVNRT 3
Atypical AVNRT  slow-slow form of AVNRT 1
AVNRT  atrioventricular node re-entrant tachycardia
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13.4% to 27.7%) in whom tachycardia could be induced
only during the Orciprenaline effect before ablation, an
electrophysiologic evaluation was accomplished also with
Orciprenaline. Tachycardias were inducible again only in a
62-year-old patient with typical AVNRT, in whom the
slow AV nodal pathway was considered ablated initially
(0.8%; CI 0.02% to 4.2%).
Complications. Three of 131 patients developed total AV
block after ablation. In another patient, deep vein throm-
bosis occurred a few days after the ablation procedure. In
this patient, a surgical intervention followed. An inherited
thrombotic disorder was diagnosed later. This results in an
overall complication rate of 3.1% (CI 0.8% to 7.6%).
Follow-up. A follow-up investigation was performed by
telephone contact with the patients and their referring
physicians. Two patients were lost to follow-up. The
follow-up period of the other 129 patients was 998 
324 days (range 222 to 1,619). Three of these patients had
a recurrence. In one patient with typical AVNRT, the
tachycardia recurred spontaneously after completion of the
ablation procedure, after uneventful stimulation before and
with Orciprenaline. After six additional high-frequency
pulses, the tachycardia was no longer inducible. No tachy-
cardia recurred in the follow-up period of 1,131 days in this
patient. In a second patient with typical AVNRT inducible
without Orciprenaline before ablation, a recurrence was
documented on the ECG two months later. The third
patient with typical AVNRT and inducibility of AVNRT
without Orciprenaline before ablation reported the same
symptoms beginning four months after the ablation proce-
dure. These paroxysms were not recorded by ECG. None of
the five patients in whom tachycardia was not inducible
before ablation, despite Orciprenaline administration, had a
recurrence of tachycardia. This results in a recurrence rate of
2.3% (CI 0.5% to 6.7%).
DISCUSSION
Atrioventricular node re-entrant tachycardias represent
(60%) the most common supraventricular tachycardias (1).
Radiofrequency catheter ablation of those tachycardias is a
routine procedure done by an interventional electrophysi-
ologist. Success rates of ablation of these tachycardias are
high (over 95%) (4,19). The question as to which criterion
is chosen for control of success remains to be answered.
Noninducibility of tachycardias after ablation under the
effect of beta-adrenergic drugs is a widely accepted criterion.
However, up until now, the extent to which this additional
Figure 1. Diagram of the course of all patients with atrioventricular nodal re-entrant tachycardia (AVNRT) before and after ablation, without and during
the effect of Orciprenaline. For more information, refer to text. P  patient.
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control stimulation is reasonable has not been systematically
investigated.
Importance of the effect of catecholamines. The portion
of AVNRTs only inducible during administration of cat-
echolamines is between 19.8% (our patient group) and
41.6% (9). The effect of catecholamines on both the
fast-conducting and slow-conducting AV nodal pathway
varies interindividually and cannot be predicted (9). Two
mechanisms are possible for the inducibility of AVNRTs,
which are only inducible during the effect of cat-
echolamines. This was shown by Hatzinikolaou et al. (9) for
isoprenaline.
• Catecholamines prolong the anterograde effective refrac-
tory period of the fast-conducting AV nodal pathway and
increase the difference between the refractory period of
the fast- and slow-conducting AV nodal pathway.
• When the difference of these refractory periods is reduced
by the action of catecholamines, AVNRTs may be
inducible if the conduction velocity of the slow-
conducting AV nodal pathway is reduced by the effect of
catecholamines and if the retrograde conduction is
improved.
Because of these effects of the catecholamines, many
investigators only consider AVNRT to be effectively ablated
if the tachycardia is not inducible during the effect of
catecholamines (2–7). Other working groups have con-
ducted stimulation for control of the success of ablation
without administration of catecholamines and do not con-
sider control stimulation with catecholamines necessary
(10,19,20).
Importance of stimulation with the effect of cat-
echolamines before ablation. In the present group of
patients, AVNRTs were inducible without additional prov-
ocation with beta-adrenergic drugs in 100 (76.3%) of all 131
patients (CI 68.1% to 83.3%). In a considerable proportion
of patients (19.8%; CI 13.4% to 27.7%) (i.e., 26 of the 131
patients with AVNRTs), the tachycardias could only be
induced during the effect of catecholamines. In the patient
group of Hatzinikolaou et al. (9), this proportion was even
greater, at 41.6%. The difference between their results and
ours is explained by their less aggressive stimulation proto-
col, as compared with the one we used, because they did not
use double extrastimuli in the atria.
Proportion of noninducibility of AVNRTs. In 5 (3.8%)
of 131 patients in our study (CI 1.3% to 8.7%), no AVNRT
was inducible, despite electrical stimulation after adminis-
tration of Orciprenaline. Bogun et al. (18) have reported on
7 (2.1%) of 331 patients who had documented regular
tachycardias with a narrow QRS complex, in whom no
tachycardia was inducible, despite stimulation during the
effect of catecholamines. In all of these patients, dual AV
node conduction behavior was detected. The diagnosis of
paroxysmal AVNRT is highly probable, but not proven.
The only criterion for the success of ablation is the occur-
rence of accelerated, junctional rhythms during energy
application. During follow-up, no patient in Bogun’s group
had a recurrence of tachycardia. Our patients were treated in
the same way, and the diagnosis of AVNRT was assumed in
these patients. The benefit of this strategy is confirmed in all
of our five patients. The proportion of noninducible AVN-
RTs in our patient cohort is similar to that of Bogun’s series
(2.1%). Lin et al. (21) have reported a frequency of 5.2% in
those patients.
Importance of control stimulation during the effect of
catecholamines after ablation. In none of our patients in
whom tachycardias were inducible without the effect of
catecholamines was tachycardia inducible after ablation. In
these patients, no tachycardia was inducible, even after
administration of catecholamines. This means that control
stimulation after ablation can be done in these patients
without additional stimulation with catecholamines, be-
cause in none of these patients would a failure of ablation or
an early recurrence of tachycardia inducibility be detected by
this additional stimulation. This was demonstrated in the
majority of all patients with AVNRT (95 [72.5%] of 131
patients; CI 64.0% to 79.9%).
In those patients in whom tachycardias are only inducible
during the effect of catecholamines before ablation, a proar-
rhythmic effect of the energy applications has to be assumed
to see inducible AVNRTs without the effect of cat-
echolamines. Stimulation without catecholamines in these
patients is not sufficient. In none of these patients was
tachycardia inducible without catecholamines after ablation.
The proportion of patients in whom tachycardia was induc-
ible during the effect of catecholamines was small (1 [3.8%]
of 26 patients [CI 0.1% to 19.6%]). If an investigator does
not accept early recurrences or failures of ablation in4% of
patients, he or she must perform control stimulation with
catecholamines in this subgroup of patients.
Importance of a waiting period after ablation. Some
investigators maintain a waiting period of 30 min after
ablation to detect early recurrences or failures of ablation
(2,10,20,22). Other investigators think that this is not
necessary (3–7,19). In all of our 121 patients in whom
AVNRTs were inducible and who were initially successfully
ablated, a waiting period of 30 min was maintained.
Induction of tachycardia after this waiting period was
possible in only one patient and only after administration of
catecholamines. This means that a recurrence of conduction
of the AV nodal pathway occurs in a maximum of 1 (0.8%)
of 121 patients (CI 0.02% to 4.5%). However, the tachy-
cardia in this patient may have been induced immediately
after the last energy application. The small number of
patients detected after a waiting period of 30 min does not
justify this waiting period.
Complications. Three of 131 patients had total AV block
after ablation, resulting in a complication rate of total AV
block of 2.3% (CI 0.5% to 6.6%), which is higher than the
1% rate expected for ablation of the slowly conducting AV
nodal pathway. This may be due to our policy of applying
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safety pulses, increasing the success rate and decreasing the
number of recurrences.
Study limitations. An exact statement regarding the num-
ber of early recurrences after ablation after a waiting period
of 30 min cannot be derived from our data, because
immediately after ablation, no stimulation was performed
according to the complete stimulation protocol. In only
0.8% of our patients was tachycardia inducible, again after a
waiting period of 30 min. This means that a maximum of
0.8% (CI 0.02% to 4.5%) of patients with a recurrence of
tachycardia inducibility can be observed after a waiting
period of 30 min. To get an exact number of early
recurrences with a waiting period of 30 min, the patients
had to be stimulated immediately after the application of the
last energy pulse and 30 min thereafter.
Conclusions. From the findings of the present study, we
conclude that in patients with AVNRTs in whom tachy-
cardia is inducible without catecholamines, stimulation with
catecholamines after ablation is not necessary in addition to
the usual control stimulation. An investigator should per-
form control stimulation in the subgroup of patients with
inducible tachycardias after catecholamine administration
only if he or she does not accept early recurrences or failures
of ablation at a rate 4%. A waiting period of 30 min after
ablation before control stimulation is not mandatory, be-
cause a recurrence rate of tachycardia inducibility of only
0.8% is to be expected.
Acknowledgment
We thank Jo Ann LeQuang for her advice in preparing the
manuscript.
Reprint requests and correspondence: Dr. Peter Weismu¨ller, De-
partment of Cardiology and Angiology, University Hospital Herne,
Ruhr-University Bochum, Ho¨lkeskampring 40, 44625 Herne, Ger-
many. E-mail: Peter.Weismueller@ruhr-uni-bochum.de.
REFERENCES
1. Jackman WM, Nakagawa H, Heidbu¨chel H, Beckman K, McClelland
J, Lazzara R. Three forms of atrioventricular nodal (junctional)
re-entrant tachycardia: differential diagnosis, electrophysiological char-
acteristics, and implications for anatomy of the re-entrant circuit. In:
Zipes DP, Jalife J, editors. Cardiac Electrophysiology. From Cell to
Bedside. Philadelphia, PA: W. B. Saunders, 1995:620–37.
2. Baker JH, Plumb VJ, Epstein AE, Kay GN. Predictors of recurrent
atrioventricular nodal reentry after selective slow pathway ablation.
Am J Cardiol 1995;3:765–9.
3. Engelstein ED, Stein KM, Markowitz SM, Lerman BB. Posterior fast
atrioventricular node pathways: implications for radiofrequency cath-
eter ablation of atrioventricular node re-entrant tachycardia. J Am Coll
Cardiol 1996;27:1098–105.
4. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of
supraventricular tachycardia due to atrioventricular nodal reentry by
radiofrequency catheter ablation of slow-pathway conduction. N Engl
J Med 1992;27:313–8.
5. Kalbfleisch SJ, Strickberger SA, Williamson B, et al. Randomized
comparison of anatomic and electrogram mapping approaches to
ablation of the slow pathway of atrioventricular node re-entrant
tachycardia. J Am Coll Cardiol 1994;23:716–23.
6. Kay GN, Epstein AE, Dailey SM, Plumb VJ. Selective radiofrequency
ablation of the slow pathway for the treatment of atrioventricular nodal
re-entrant tachycardia: evidence of involvement of perinodal myocar-
dium within the re-entrant circuit. Circulation 1992;85:1675–88.
7. Tai CT, Chen SA, Chian CE, et al. Multiple anterograde atrioven-
tricular node pathways in patients with atrioventricular node re-entrant
tachycardia. J Am Coll Cardiol 1996;298:725–31.
8. Weiner N. Norepinephrine, epinephrine, and the sympathomimetic
amines. Goodman-Gilman A, Rall TW, Nies AS, Taylor P, eds.
Goodman & Gilman’s The Pharmacological Basis of Therapeutics,
8th ed. New York, NY: Macmillan, 1992.
9. Hatzinikolaou H, Rodriguez LM, Smeets JL, et al. Isoprenaline and
inducibility of atrioventricular nodal re-entrant tachycardia. Heart
1998;79:165–8.
10. Pfeiffer D, Tebbenjohanns J, Schumacher B, Jung W, Lu¨deritz B.
Methoden, Topographie und Mechanismen der Radiofrequenzabla-
tion von AV-Knoten-Reentry-Tachykardien. Z Kardiol 1994;83:877–
86.
11. Klug D, Lacroix F, Le FP, et al. Single radiofrequency application to
cure atrio-ventricular nodal reentry: arguments for the slow pathway
origin of the high-low frequency slow potentials. J Interv Card
Electrophysiol 1998;2:77–86.
12. Stabile G, De Simone A, Solimene F, Turco P, Rotunno R, Di Napoli
T. The predictive value of junctional beats during the radiofrequency
transcatheter ablation of the slow pathway of the nodal reentry circuit.
G Ital Cardiol 1999;29:549–54.
13. Weismu¨ller P. AV-Knoten-Reentry-Tachykardie - Diagnostik und
Katheterablation. In: Thamasett S, Hombach V, eds. Mappingver-
fahren in der Elektrophysiologie: ein aktueller U¨berblick. Darmstadt:
Steinkopff, 2000;31–45.
14. Lee MA, Morady F, Kadish A. Catheter modification of the atrio-
ventricular junction with radiofrequency energy for control of atrio-
ventricular nodal reentry tachycardia. Circulation 1991;83:827–35.
15. Manolis AS, Wang PJ, Estes NA. Radiofrequency ablation of slow
pathway in patients with atrioventricular nodal re-entrant tachycardia:
do arrhythmia recurrences correlate with persistent slow pathway
conduction or site of successful ablation? Circulation 1994;90:2815–9.
16. Silva MA, Scanavacca MI, Da´vila A, Kuniyoshi R, Sosa EA. Rela-
tionship between conduction persistence through the slow pathway
after atrioventricular nodal reentry tachycardia radiofrequency ablation
and its recurrence. Arq Bras Cardiol 1998;71:117–20.
17. Gardner MJ, Altman DG. Statistics with confidence. Confidence
intervals and statistical guidelines. London: British Medical Journal
Publishing Group, 1994.
18. Bogun F, Knight B, Weiss R, et al. Slow pathway ablation in patients
with documented but noninducible paroxysmal supraventricular tachy-
cardia. J Am Coll Cardiol 1996;28:1000–4.
19. Haissaguerre M, Gaita F, Fischer B, et al. Elimination of atrioven-
tricular nodal re-entrant tachycardia using discrete slow potentials to
guide application of radiofrequency energy. Circulation 1992;85:2162–
75.
20. Calkins H, Prystowsky E, Berger RD, et al, and the Atakr Multicenter
Investigators Group. Recurrence of conduction following radiofre-
quency catheter ablation procedures: relationship to ablation target and
electrode temperature. J Cardiovasc Electrophysiol 1996;7:704–13.
21. Lin JL, Huang SKS, Lai LP, Ko WC, Tseng YZ, Lien WP. Clinical
and electrophysiologic characteristics and long-term efficacy of slow-
pathway catheter ablation in patients with spontaneous supraventric-
ular tachycardia and dual atrioventricular node pathways without
inducible tachycardia. J Am Coll Cardiol 1998;15:855–60.
22. Jazayeri MR, Hempe SL, Sra JS, et al. Selective transcatheter ablation
of the fast and slow pathways using radiofrequency energy in patients
with atrio-ventricular nodal re-entrant tachycardia. Circulation 1992;
85:1318–28.
694 Weismu¨ller et al. JACC Vol. 39, No. 4, 2002
Catecholamines for Control After Ablation of AVNRT February 20, 2002:689–94
